About Dysport IPSEN
Dysport IPSEN is a botulinum toxin type A preparation manufactured by IPSEN Pharmaceuticals, widely investigated in laboratory studies examining neuromuscular junction mechanisms and muscle contraction pathways. This research-grade compound represents one of the most extensively studied botulinum formulations, with over three decades of scientific literature documenting its molecular properties and biological activities. Researchers at Stroid UK Shop can access pharmaceutical-grade preparations for controlled laboratory investigations examining neurotoxin mechanisms, protein interactions, and cellular response pathways.
Laboratory Applications
Scientific studies utilise Dysport in various research contexts, including neuromuscular transmission investigations, muscle physiology research, and neurological pathway mapping. The compound’s mechanism involves cleaving SNARE proteins at nerve terminals, making it valuable for studying synaptic vesicle fusion processes and neurotransmitter release mechanisms. Researchers examine its interactions with VAMP-2 proteins and effects on acetylcholine release in controlled experimental settings. Laboratory protocols often investigate dose-response relationships, onset kinetics, and duration of biological activity in tissue culture systems. Studies exploring botulinum toxin preparations frequently compare formulation differences and potency variations between manufacturers.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Botulinum Toxin Type A |
| Manufacturer | IPSEN Pharmaceuticals |
| CAS Number | 93384-43-1 |
| Molecular Weight | ~150 kDa |
| Storage Temperature | 2-8°C |
| Reconstitution | Sterile saline per protocol |
Researchers also investigate complementary compounds available through our SARM collections and peptide research materials for comparative neurobiology studies.
Research Compliance
This product is supplied exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or clinical applications. All research must comply with institutional guidelines and local regulations governing botulinum toxin handling and storage protocols.
